Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 2252 to 2301 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2252\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSKETOLASE-LIKE 1 (EC 2.2.1.1) (TRANSKETOLASE 2) (TK 2) (TRANSKETOLASE RELATED PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0765571\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.343091\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.223139342\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TKTL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2253\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY GAMMA SUBUNIT (PI3-KINASE P85-GAMMA SUBUNIT) (PTDINS-3-KINASE P85-GAMMA) (P55PIK). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0597741\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.267978\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.223055997\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PIK3R3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2254\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0309189\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.138615\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.223055946\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C7orf24\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2255\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STEROL REGULATORY ELEMENT BINDING PROTEIN CLEAVAGE-ACTIVATING PROTEIN (SREBP CLEAVAGE-ACTIVATING PROTEIN) (SCAP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0868591\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.389405\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.223055944\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SCAP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2256\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY ALPHA SUBUNIT (PI3-KINASE P85-ALPHA SUBUNIT) (PTDINS-3-KINASE P85-ALPHA) (PI3K). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0593799\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.266211\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.223055772\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PIK3R1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2257\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.086859\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.389405\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.223055688\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2258\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY BETA SUBUNIT (PI3-KINASE P85-BETA SUBUNIT) (PTDINS-3-KINASE P85-BETA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0560483\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.251275\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.223055616\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PIK3R2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2259\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RING FINGER PROTEIN 38. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0582358\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.261082\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.223055592\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RNF38\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2260\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RING FINGER PROTEIN 44. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0536444\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.240498\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.223055493\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RNF44\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2261\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0308958\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.138512\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.223055042\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATPAF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2262\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ATP SYNTHASE BETA CHAIN, MITOCHONDRIAL PRECURSOR (EC 3.6.3.14). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.366428\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.64277\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.223054962\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP5B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2263\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEUROTRYPSIN PRECURSOR (EC 3.4.21.-) (MOTOPSIN) (LEYDIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.11794\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.528749\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.223054795\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRSS12\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2264\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RIBONUCLEASE P PROTEIN SUBUNIT P30 (EC 3.1.26.5) (RNASEP PROTEIN P30) (RNASE P SUBUNIT 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.174876\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.784403\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222941524\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPP30\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2265\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SHWACHMAN-BODIAN-DIAMOND SYNDROME PROTEIN (CGI-97). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.149637\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.671325\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222898\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SBDS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2266\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TOPOISOMERASE-RELATED FUNCTION PROTEIN 4-2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0534133\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.239746\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222791204\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PAPD5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2267\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLYMERASE (DNA DIRECTED) SIGMA; TOPOISOMERASE-RELATED FUNCTION PROTEIN 4-1; POLYMERASE (DNA-DIRECTED) SIGMA. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0673124\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.302153\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222775878\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
POLS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2268\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LEUKOTRIENE A-4 HYDROLASE (EC 3.3.2.6) (LTA-4 HYDROLASE) (LEUKOTRIENE A(4) HYDROLASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0297305\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.133476\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222740418\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LTA4H\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2269\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"DIHYDROOROTATE DEHYDROGENASE, MITOCHONDRIAL PRECURSOR (EC 1.3.3.1) (DIHYDROOROTATE OXIDASE) (DHODEHASE) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.314489\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.41191\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222740118\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DHODH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2270\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUROMYCIN-SENSITIVE AMINOPEPTIDASE (EC 3.4.11.-) (PSA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0267797\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.120229\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222739106\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NPEPPS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2271\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLYCEROL KINASE (EC 2.7.1.30) (ATP:GLYCEROL 3-PHOSPHOTRANSFERASE) (GLYCEROKINASE) (GK). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.129279\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.58046\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222718189\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2272\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GLYCEROL KINASE, TESTIS SPECIFIC 1 (EC 2.7.1.30) (ATP:GLYCEROL 3- PHOSPHOTRANSFERASE) (GLYCEROKINASE) (GK). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.131767\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.591632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222717838\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2273\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GLYCEROL KINASE, TESTIS SPECIFIC 2 (EC 2.7.1.30) (ATP:GLYCEROL 3- PHOSPHOTRANSFERASE) (GLYCEROKINASE) (GK). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.137099\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.615573\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222717696\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2274\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOCHONDRIAL TRANSLATIONAL RELEASE FACTOR 1-LIKE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.183185\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.822563\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222700267\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MTRF1L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2275\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.294007\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.32025\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2226904\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2276\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MANNOSE-P-DOLICHOL UTILIZATION DEFECT 1 PROTEIN (SUPPRESSOR OF LEC15 AND LEC35 GLYCOSYLATION MUTATION HOMOLOG) (SL15). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0556491\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.249916\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222671218\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MPDU1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2277\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PEPTIDE CHAIN RELEASE FACTOR 1, MITOCHONDRIAL PRECURSOR (MRF-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.142292\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.639129\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222634241\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MTRF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2278\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIPHTHAMIDE BIOSYNTHESIS-LIKE PROTEIN 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.346955\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.55897\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222553994\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DPH2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2279\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.152886\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.687157\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222490639\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GDPD3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2280\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"28S RIBOSOMAL PROTEIN S16, MITOCHONDRIAL PRECURSOR (MRP-S16) (CGI- 132). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.12797\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.575175\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222488808\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MRPS16\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2281\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN (P14.5) (UK114 ANTIGEN HOMOLOG). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0509775\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.229168\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222445978\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HRSP12\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2282\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNA-DIRECTED RNA POLYMERASE II 14.4 KDA POLYPEPTIDE (EC 2.7.7.6) (RPB6) (RPB14.4) (RPABC2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.848404\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.81401\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222444094\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
POLR2F\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2283\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.188344\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.846836\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222409061\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GDPD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2284\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
APOLIPOPROTEIN A-I BINDING PROTEIN; APOA-I BINDING PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.180926\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.813521\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222398684\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
APOA1BP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2285\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNA-DIRECTED RNA POLYMERASE II 13.3 KDA POLYPEPTIDE (EC 2.7.7.6) (RPB11). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.249308\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.12113\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222372071\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
POLR2J\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2286\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.147358\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.662751\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222342931\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAP3K7IP3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2287\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN DLX-2. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0581957\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.261739\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.222342486\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
DLX2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2288\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MBD2 (METHYL-CPG-BINDING PROTEIN)-INTERACTING ZINC FINGER PROTEIN. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
MIZF\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2289\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7 INTERACTING PROTEIN 2 ISOFORM 1; TAK1-BINDING PROTEIN 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.11552\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.519559\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.22234241\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAP3K7IP2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2290\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN DLX-5. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0443146\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.199308\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222342304\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DLX5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2291\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEURONAL TROPOMODULIN (N-TMOD) (TROPOMODULIN 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0273103\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.12283\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222342262\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TMOD2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2292\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBIQUITOUS TROPOMODULIN (U-TMOD) (TROPOMODULIN 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0276089\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.124173\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222342216\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TMOD3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2293\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TROPOMODULIN 1 (ERYTHROCYTE TROPOMODULIN) (E-TMOD). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0322816\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.145189\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.222341913\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
TMOD1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2294\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTIVATED P21CDC42HS KINASE. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
TNK2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2295\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SKELETAL MUSCLE TROPOMODULIN (SK-TMOD) (TROPOMODULIN 4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0274232\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.123338\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222341857\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TMOD4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2296\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FETAL BRAIN PROTEIN 239 (239FB). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.121524\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.546564\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222341757\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MPPED2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2297\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SORTING NEXIN 9 (SH3 AND PX DOMAIN-CONTAINING PROTEIN 1) (SDP1 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.237383\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.06765\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222341591\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SNX9\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2298\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN DLX-3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0439756\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.197784\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222341544\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DLX3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2299\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSCRIPTION INITIATION FACTOR TFIID 20/15 KDA SUBUNITS (TAFII- 20/TAFII-15) (TAFII20/TAFII15). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.396471\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.78321\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222335563\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TAF12\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2300\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SORTING NEXIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.327115\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.47133\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222326059\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SNX1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2301\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
P10-BINDING PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.10445\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.469849\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.222305464\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CEP70\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/